Author:
Sheldon Breanna L.,Olmsted Zachary T.,Sabourin Shelby,Heydari Ehsaun,Harland Tessa A.,Pilitsis Julie G.
Abstract
Central neuropathic pain (CNP) affects millions worldwide, with an estimated prevalence of around 10% globally. Although there are a wide variety of treatment options available, due to the complex and multidimensional nature in which CNP arises and presents symptomatically, many patients still experience painful symptoms. Pharmaceutical, surgical, non-invasive, cognitive and combination treatment options offer a generalized starting point for alleviating symptoms; however, a more customized approach may provide greater benefit. Here, we comment on the current treatment options that exist for CNP and further suggest the need for additional research regarding the use of biomarkers to help individualize treatment options for patients.
Reference89 articles.
1. Dydyk, A.M., and Givler, A. (2022). Central Pain Syndrome, StatPearls Publishing.
2. Neuropathic Pain: From Mechanisms to Treatment;Finnerup;Physiol. Rev.,2021
3. Central Neuropathic Pain Syndromes;Watson;Mayo Clin. Proc.,2016
4. Neuropathic Pain: Central vs. Peripheral Mechanisms;Meacham;Curr. Pain Headache Rep.,2017
5. Jahngir, M.U., and Qureshi, A.I. (2022). Dejerine Roussy Syndrome, StatPearls Publishing.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献